insights_auto
Why is GH down 2,17%?
Dive Deeperchevron_right
GH:NASDAQ
Guardant Health Inc
US$155,35
arrow_downward
-2,17%(-3,44) 1D
US$155,35
0,00% (0,00)
bedtimeAfter hours
Closed: 10 ພ.ຈ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
US$158,71
High
US$160,94
Low
US$153,00
Mkt. cap
21,02 ຕື້
Avg. vol.
2,06 ລ້ານ
Volume
29,00
52-wk high
US$191,01
52-wk low
US$74,55
EPS
US$-3,68
Beta
1,67
Shares outstanding
135,29 ລ້ານ
No. of employees
2 ພັນ
Open
US$158,71
High
US$160,94
Low
US$153,00
Mkt. cap
21,02 ຕື້
Avg. vol.
2,06 ລ້ານ
Volume
29,00
52-wk high
US$191,01
52-wk low
US$74,55
EPS
US$-3,68
Beta
1,67
Shares outstanding
135,29 ລ້ານ
No. of employees
2 ພັນ
News stories
From web sources and news partners
Seeking Alpha
·
11 ຊົ່ວໂມງກ່ອນ
Guardant Health, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:GH) 2026-11-10
Trefis
·
1 ມື້ກ່ອນ
What Sent Guardant Health Stock Higher?
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 ພັນ
Founded2012
HeadquartersPalo Alto, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorHealth Care
IndustryHealth care provider
Websiteguardanthealth.com